17-50194694-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000088.4(COL1A1):​c.1461+27G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.68 in 1,558,118 control chromosomes in the GnomAD database, including 361,389 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.70 ( 37640 hom., cov: 30)
Exomes 𝑓: 0.68 ( 323749 hom. )

Consequence

COL1A1
NM_000088.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.19

Publications

16 publications found
Variant links:
Genes affected
COL1A1 (HGNC:2197): (collagen type I alpha 1 chain) This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
COL1A1 Gene-Disease associations (from GenCC):
  • Caffey disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Ambry Genetics
  • COL1A1-related Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: ClinGen, Ambry Genetics
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, arthrochalasia type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • osteogenesis imperfecta
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • osteogenesis imperfecta type 1
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • osteogenesis imperfecta type 4
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet
  • Ehlers-Danlos syndrome, classic type, 1
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ehlers-Danlos/osteogenesis imperfecta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • high bone mass osteogenesis imperfecta
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 17-50194694-C-T is Benign according to our data. Variant chr17-50194694-C-T is described in ClinVar as Benign. ClinVar VariationId is 674802.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.746 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000088.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL1A1
NM_000088.4
MANE Select
c.1461+27G>A
intron
N/ANP_000079.2P02452

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL1A1
ENST00000225964.10
TSL:1 MANE Select
c.1461+27G>A
intron
N/AENSP00000225964.6P02452
COL1A1
ENST00000861334.1
c.1461+27G>A
intron
N/AENSP00000531393.1
COL1A1
ENST00000861339.1
c.1461+27G>A
intron
N/AENSP00000531398.1

Frequencies

GnomAD3 genomes
AF:
0.702
AC:
106514
AN:
151674
Hom.:
37599
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.753
Gnomad AMI
AF:
0.697
Gnomad AMR
AF:
0.746
Gnomad ASJ
AF:
0.699
Gnomad EAS
AF:
0.627
Gnomad SAS
AF:
0.637
Gnomad FIN
AF:
0.688
Gnomad MID
AF:
0.675
Gnomad NFE
AF:
0.674
Gnomad OTH
AF:
0.712
GnomAD2 exomes
AF:
0.685
AC:
114975
AN:
167896
AF XY:
0.678
show subpopulations
Gnomad AFR exome
AF:
0.756
Gnomad AMR exome
AF:
0.768
Gnomad ASJ exome
AF:
0.706
Gnomad EAS exome
AF:
0.637
Gnomad FIN exome
AF:
0.679
Gnomad NFE exome
AF:
0.675
Gnomad OTH exome
AF:
0.701
GnomAD4 exome
AF:
0.678
AC:
952803
AN:
1406328
Hom.:
323749
Cov.:
38
AF XY:
0.674
AC XY:
468359
AN XY:
694668
show subpopulations
African (AFR)
AF:
0.757
AC:
24126
AN:
31850
American (AMR)
AF:
0.763
AC:
27914
AN:
36574
Ashkenazi Jewish (ASJ)
AF:
0.705
AC:
17823
AN:
25282
East Asian (EAS)
AF:
0.641
AC:
23192
AN:
36186
South Asian (SAS)
AF:
0.611
AC:
49105
AN:
80350
European-Finnish (FIN)
AF:
0.676
AC:
33510
AN:
49558
Middle Eastern (MID)
AF:
0.681
AC:
3884
AN:
5702
European-Non Finnish (NFE)
AF:
0.678
AC:
733631
AN:
1082508
Other (OTH)
AF:
0.679
AC:
39618
AN:
58318
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
18291
36582
54873
73164
91455
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19118
38236
57354
76472
95590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.702
AC:
106610
AN:
151790
Hom.:
37640
Cov.:
30
AF XY:
0.702
AC XY:
52082
AN XY:
74208
show subpopulations
African (AFR)
AF:
0.753
AC:
31161
AN:
41376
American (AMR)
AF:
0.746
AC:
11395
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.699
AC:
2424
AN:
3470
East Asian (EAS)
AF:
0.627
AC:
3213
AN:
5122
South Asian (SAS)
AF:
0.636
AC:
3063
AN:
4818
European-Finnish (FIN)
AF:
0.688
AC:
7255
AN:
10546
Middle Eastern (MID)
AF:
0.695
AC:
203
AN:
292
European-Non Finnish (NFE)
AF:
0.674
AC:
45761
AN:
67872
Other (OTH)
AF:
0.713
AC:
1502
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
1506
3012
4518
6024
7530
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
816
1632
2448
3264
4080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.649
Hom.:
4479
Bravo
AF:
0.712
Asia WGS
AF:
0.634
AC:
2207
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.14
DANN
Benign
0.82
PhyloP100
-2.2
Mutation Taster
=52/48
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2253369; hg19: chr17-48272055; COSMIC: COSV56806193; COSMIC: COSV56806193; API